Presented By: Yann Christinat, PhD & Stephan Bartels, PhD
Webinar: HRD Evaluation and Scoring using OncoScan CNV Assay, a whole-genome microarray research solution
Webinar Abstract: Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhibitors, induce synthetic lethality in tumors with high levels of HRD...
Labroots on Social:
Facebook: / labrootsinc
Twitter: / labroots
LinkedIn: / labroots
Instagram: / labrootsinc
Pinterest: / labroots
SnapChat: labroots_inc